When Food and Drug Administration (FDA) enacted the Drug Supply Chain Security Act (DSCSA) in 2013, it set a 10-year timeline for full implementation. November 2023 marks the end of that timeline.

A significant portion of this last milestone requires the entire supply chain to become interoperable using secure and electronic means. One requirement that is included in Title II of the Act calls for product tracing at the package level, which has not been explored widely by the industry until recently. NABP’s DSCSA State Regulator Pilot project tested a system for sharing this information between regulators and trading partners, including distributors, manufacturers, and others.

More information is available in a blog article posted to the NABP website, available at https://nabp.pharmacy/news/blog/how-pharmacies-can-prep-now-for-the-2023-dscsa-requirements.